PCN175 - BRENTUXIMAB VEDOTIN COMPARED WITH STANDARD THERAPY FOR PATIENTS WITH ADVANCED-STAGE HODGKIN’S LYMPHOMA- A COST-EFFECTIVENESS ANALYSIS
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.258
https://www.valueinhealthjournal.com/article/S1098-3015(18)33558-7/fulltext
Title :
PCN175 - BRENTUXIMAB VEDOTIN COMPARED WITH STANDARD THERAPY FOR PATIENTS WITH ADVANCED-STAGE HODGKIN’S LYMPHOMA- A COST-EFFECTIVENESS ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33558-7&doi=10.1016/j.jval.2018.09.258
First page :
Section Title :
Open access? :
No
Section Order :
1953